Evidence map›Paper›PMID 42308420›Full record

ArticleBriefings in bioinformatics2026

MAPLE: interpretable deep learning identifies selective antimicrobial peptides using joint evolutionary-physicochemical analysis.

Hao Liu, Yi Shi, Feiyu Guo, Jinyi Wang, Jiaqian Li, Guangji Wang, De-Chuan Zhan, Haiping Hao, Guo Yu

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hao LiuState Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism, China Pharmaceutical University, No. 24 Tongjiaxiang, Gulou District, Nanjing 210009, China.
Yi ShiState Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism, China Pharmaceutical University, No. 24 Tongjiaxiang, Gulou District, Nanjing 210009, China.
Feiyu GuoSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, No. 639 Longmian Avenue, Jiangning District, Nanjing 211198, China.
Jinyi WangSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, No. 639 Longmian Avenue, Jiangning District, Nanjing 211198, China.
Jiaqian LiSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, No. 639 Longmian Avenue, Jiangning District, Nanjing 211198, China.
Guangji WangState Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism, China Pharmaceutical University, No. 24 Tongjiaxiang, Gulou District, Nanjing 210009, China.
De-Chuan ZhanNational Key Laboratory for Novel Software Technology, Nanjing University, No. 163 Xianlin Avenue, Qixia District, Nanjing 210023, China.
Haiping HaoState Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism, China Pharmaceutical University, No. 24 Tongjiaxiang, Gulou District, Nanjing 210009, China.
Guo YuState Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism, China Pharmaceutical University, No. 24 Tongjiaxiang, Gulou District, Nanjing 210009, China.ORCID 0000-0001-6685-2167

Funding

Lingang Laboratory LGL-2615-04
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are promising alternatives to conventional antibiotics, yet early translation is often hindered by the perceived coupling between antibacterial potency and mammalian toxicity. This assumption complicates prioritization: highly active candidates are frequently suspected to be hemolytic, while existing multi-task predictors rarely reveal where selectivity resides in sequence space. Here, we present Multifunctional AMP Learning Engine (MAPLE), an interpretable dual-stream framework for AMP identification and systematic category-specific functional profiling across 14 activity categories directly from peptide sequences. MAPLE combines protein language model embeddings with explicit physicochemical descriptors, enabling robust task-specific prediction under severe label imbalance. Across the benchmark dataset and a sequence-non-overlapping independent validation set, MAPLE achieves consistently well-balanced performance, including on low-prevalence but clinically relevant endpoints. Building on this predictive basis, we conduct systematic k-mer enrichment to map motif-level selectivity and show that potency-hemolysis coupling is motif-regime-dependent rather than universal. Motifs most strongly enriched for antibacterial activity exhibit reduced hemolytic overlap and occupy a physicochemical regime characterized by moderate cationicity, lower hydrophobicity, and higher amphipathicity. We further provide a proof-of-concept prioritization workflow leveraging antibacterial-selective motifs, with structural modeling yielding conformations consistent with amphipathic α-helices. Despite limitations of predominantly binary annotations and incomplete structural integration, MAPLE offers reproducible sequence-level hypotheses and prioritization principles to support the engineering of potent and safer AMPs.

Indexed as

Antimicrobial PeptidesComputational BiologyDeep LearningAmino Acid SequenceHemolysisHumansAntimicrobial Peptidesantimicrobial peptidesfunctional profilinghemolysis predictionmotif interpretabilityprotein language modelstherapeutic selectivity

Identifiers

PMID42308420
PMCPMC13274993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.